A healthy journey is ahead.
For the next 10 days, you’ll explore your Dexcom G7 and everything it has to offer. Bookmark this page as a helpful guide for each day, and watch your email for additional reminders and tips. Your journey to better diabetes management starts now.
Days 1-2
Your glucose numbers tell the story.
It’s all about small steps and positive habits. Enjoy getting familiar with how Dexcom G7 helps you keep track of your glucose.
On days 1 and 2, try to follow your normal routine and watch how your glucose levels change after meals or insulin doses.
Notice how your symptoms align with the Dexcom G7 app* data, and keep in mind that you may not be used to seeing your levels change in real time.
Days 3-4
Make it just right – for you.
Alerts. Events. Sounds. Followers ‡. It’s all customizable.
Now that you’ve had a few days with your Dexcom G7, review your preferences and make any desired adjustments. You can tailor options like high and low threshold alerts, Quiet Mode, and alert sounds to fit your lifestyle.
A heads-up: Before changing your alert settings, talk with your healthcare professional.
Days 5-6
Learn from your meals.
How did your breakfast affect your glucose today? Did your afternoon snack raise your numbers?
Dexcom G7 makes it possible to watch how food impacts your glucose numbers in real time, with readings as frequent as up to every five minutes.
It’s all designed to help you keep an eye on your progress and reach your diabetes management goals.
Days 7-8
Clarity comes with insights.
By now, you’ve been using Dexcom G7 for a week. If you haven’t already, then be sure to explore the Dexcom Clarity** summary feature within the Dexcom G7 app.
In the Dexcom G7 app, you can see high-level glucose insights on the Dexcom Clarity card that’s built into the home screen. It populates once it has enough data to define trends, helping you gauge how you’re doing. The more you know, the easier it is to stay in range, which can lower your A1C. 1-6
If you want to use the Dexcom Clarity app on its own, then you can also download it from the Apple App Store or the Google Play Store.
Days 9-10
We’re just getting started.
Congrats! Your sample of Dexcom G7 is almost finished, but your journey to a better A1C and more time in range doesn’t have to be.
Ask yourself: How do you feel? What did you learn about your glucose this week? Did you identify any patterns? How did Dexcom G7 and the Dexcom Clarity app help you manage your diabetes? What new questions do you have for your healthcare professional?
This step is just the beginning, and it gets even better from here. Watch your email for instructions on how you can continue your Dexcom G7 journey to better diabetes management.
Indications for Use:
The Dexcom G7 Continuous Glucose Monitoring System (Dexcom G7 CGM System or G7) is a glucose monitoring system indicated for continuously measuring glucose in the interstitial fluid in persons age 2 years and older. The Dexcom G7 CGM System is designed to replace fingerstick blood glucose (BG) testing for treatment decisions. Interpretation of the Dexcom G7 CGM System results should be based on glucose trends and several sequential sensor readings over time. The Dexcom G7 CGM System also aids in the detection of episodes of hyperglycemia and hypoglycemia, facilitating both acute and long-term therapy adjustments. The Dexcom G7 CGM System is intended for use by patients at home and in healthcare facilities.
* If your glucose alerts and readings from Dexcom G7 do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.
‡ While connected to the internet with consent to share data. Separate Follow app and stable internet connection required. Users should always confirm readings on the Dexcom G7 app or receiver before making treatment decisions.
** Notifications and emails are only available for users who opt in and use the Dexcom CGM app. The web-based Dexcom Clarity software is intended for use by both home users and healthcare professionals to assist people with diabetes in the review, analysis, and evaluation of historical CGM data to support effective diabetes management. It is intended for use as an accessory to Dexcom CGM devices with data interface capabilities. Caution: The software does not provide any medical advice and should not be used for that purpose. Home users must consult a healthcare professional before making any medical interpretation and therapy adjustments from the information in the software. Caution: Healthcare professionals should use information in the software in conjunction with other clinical information available to them.
‡ While connected to the internet with consent to share data. Separate Follow app and stable internet connection required. Users should always confirm readings on the Dexcom G7 app or receiver before making treatment decisions.
** Notifications and emails are only available for users who opt in and use the Dexcom CGM app. The web-based Dexcom Clarity software is intended for use by both home users and healthcare professionals to assist people with diabetes in the review, analysis, and evaluation of historical CGM data to support effective diabetes management. It is intended for use as an accessory to Dexcom CGM devices with data interface capabilities. Caution: The software does not provide any medical advice and should not be used for that purpose. Home users must consult a healthcare professional before making any medical interpretation and therapy adjustments from the information in the software. Caution: Healthcare professionals should use information in the software in conjunction with other clinical information available to them.
1 Beck RW, et al. JAMA. 2017;317(4):371-378.
2 Beck RW, et al. Ann Intern Med. 2017;167(6):365-374.
3 Martens T, et al. JAMA. 2021;325(22):2262-2272.
4 Laffel LM, et al. JAMA. 2020;323(23):2388-2396.
5 Welsh JB, et al. J Diabetes Sci Technol. 2022:19322968221099879.
6 Heinemann L, et al. Lancet 2018;391 :1367-77.
2 Beck RW, et al. Ann Intern Med. 2017;167(6):365-374.
3 Martens T, et al. JAMA. 2021;325(22):2262-2272.
4 Laffel LM, et al. JAMA. 2020;323(23):2388-2396.
5 Welsh JB, et al. J Diabetes Sci Technol. 2022:19322968221099879.
6 Heinemann L, et al. Lancet 2018;391 :1367-77.
Dexcom, Dexcom Follow, Dexcom Clarity, Dexcom Share, Share, and Dexcom ONE are registered trademarks of Dexcom, Inc. in the U.S. and may be registered in other countries. Dexcom, Dexcom Clarity, Dexcom Follow, Dexcom One, Dexcom Share, and Share are trademarks or registered trademarks in the U.S. and may be in other countries.
COPYRIGHT © 2023 DEXCOM CANADA, CO. ALL RIGHTS RESERVED. This product is covered by U.S. patent.
COPYRIGHT © 2023 DEXCOM CANADA, CO. ALL RIGHTS RESERVED. This product is covered by U.S. patent.
MAT-0324